Longeveron Announces Potential Biomarker Correlating with Lomecel-B Bioactivity

NEXT STORY
Mountain Valley MD Holdings Provides Business Update, Results of Shareholder Meeting
PREV STORY
SCYNEXIS Presents Interim Analysis from FURI at Virtual IDWeek 2021 Showing Favorable Therapeutic Response in Severe Hospital-Based Fungal Infections Treated with Oral Ibrexafungerp
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TG Therapeutics Announces Launch of the ULTRA-V Phase 3 Trial Evaluating the Triple Combination of UKONIQ™ (umbralisib), Ublituximab, and Venetoclax

author_avatar
NASDAQ Market News

Halal Pharmaceuticals Market to Hit $174.59 Billion by 2025 – Global Insights On Source Material, Products, Drug Class, Regulatory Framework, Vendor Landscape and Value Chain Analysis: Adroit Market Research

author_avatar
NASDAQ Market News

Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development

author_avatar
NASDAQ Market News